Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157)
Financial Results:
Cipla Ltd reported Revenues for Q4FY25 of ₹6,730.00 Crores up from ₹6,163.00 Crore year on year, a rise of 9.2%.
Total Expenses for Q4FY25 of ₹5,515.00 Crores up from ₹5,153.00 Crores year on year, a rise of 7.03%.
Consolidated Net Profit of ₹1,214.00 Crores up 30.26% from ₹932.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹15.13, up 30.09% from ₹11.63 in the same quarter of the previous year.